Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cold-treating granules (治伤风颗粒) is a combination pharmaceutical drug used to relieve symptoms of the common cold. It contains a blend of Western pharmaceutical ingredients and traditional Chinese medicinal herbs. The Western active ingredients include acetaminophen (paracetamol), caffeine, noscapine, and chlorphenamine maleate, which provide analgesic, antipyretic, antitussive, and antihistaminic effects, respectively. The herbal components, such as Pueraria lobata, Ephedra, Cinnamon twig, White peony root, Jujube, Ginger, Licorice, and Ginseng, are traditionally used to dispel wind-cold, relieve exterior symptoms, and clear heat, contributing to overall symptomatic relief. It is administered orally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cold-treating granules.